1-14 of 14
Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Super-Enhancer Profiling Identifies Novel Oncogenes and Therapeutic Targets in Multiple Myeloma

Jianbiao Zhou, MD PhD, Yunlu Jia, MD, Tze King Tan, PhD, Tae-Hoon Chung, PhD, Takaomi Sanda, MD PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2019) 134 (Supplement_1): 362.
https://doi.org/10.1182/blood-2019-124252
Published: 2019
Journal Articles

Protocol for an International, Multi-Centre, Retrospective Study to Describe Treatment Pathways, Outcomes and Resource Use in Patients with Multiple Myeloma (INTEGRATE)

Su-Peng Yeh, MD, Fahad Alsharif, MD DIM, MB ChB, Meral Beksac, MD, Wenming Chen, PhD, Dorotea Fantl, MD, Tatiana Mitina, MD PhD, Estelle Verburgh, MBChB, M MDInt, FCPSA, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kwang-Wei Wu, MD, Zijing Zhang, PhD, Hui Wan, MD PhD, Kihyun Kim, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5577.
https://doi.org/10.1182/blood-2019-122732
Published: 2019
Journal Articles

Potential IL6R-ADAR1-STAT3 Interplay Promotes Oncogenicity in 1q21(amp) Multiple Myeloma

Phaik Ju Teoh, PhD, Tae-Hoon Chung, Leilei Chen, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4513.
https://doi.org/10.1182/blood-2018-99-118895
Published: 2018
Journal Articles

NSD2 Interacts with SMARCA2 and Regulates Expression of Oncogenes CCND1 and PRL3 in T(4;14) Multiple Myeloma

Jing Yuan Chooi, BSc, Zhigang Xie, PhD, Jayantha Gunaratne, PhD, Dennis Keppei, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4479.
https://doi.org/10.1182/blood-2018-99-110671
Published: 2018
Journal Articles

CD55 and CD59 Can Limit the Anti-Tumor Efficacy of Daratumumab in Natural Killer/T-Cell Lymphoma

Nurulhuda Mustafa, PhD, Adina Huey Fang Nee, BSc, Jing Yuan Chooi, BSc, Sabrina Hui Min Toh, BSc, Yan Ting Hee, BSc, Viknesvaran Selvarajan, PhD, Longen Zhou, PhD, Jennifer Yang, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 1663.
https://doi.org/10.1182/blood-2018-99-115566
Published: 2018
Journal Articles

Pharmacogenomic Prediction of Bleomycin-Induced Pneumonitis in South East Asian Hodgkin Lymphoma Patients

Joanne Shu Xian Lee, MBBS, MRCP, Li Mei Poon, MBBS, MRCP, FRCPath, Xin Liu, Yi Ching Yuen, BPharm, Nagavalli Somasundaram, MBBS, MRCP, Suk Teng Chin, Chia Meng Teoh, MBBS, Benedict Yan, MBBS, Hian Li Esther Hian Li Chan, MBBS, Yen-Lin Chee, MBBS, MRCP, FRCPath, Tiffany Tang, MBBS, MRCP, Noorul Farzana, Caroline Hui Ting Aw, Chiea Chuen Khor, MD PhD, Joanne Yuen Yie Ngeow, BMedSci, MBBS, MRCP, FAMS, Choon Kiat Ong, PhD, E Shyong Tai, MB ChB, MRCP, FRCP, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Boon Cher Goh, MBBS, MRCP, M.MD FRCP, Soo Chin Lee, MBBS, MRCP, M.MD FRCP, FAMS, Folefac Aminkeng, BMLS, MSc, PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4111.
https://doi.org/10.1182/blood-2018-99-113952
Published: 2018
Journal Articles

Single Institution Phase 1 Study on Combination Therapy of Midostaurin and Panobinostat in Acute Myeloid Leukemia - the Interim Report

Chin-Hin NG, MD MRCP, FRPATH, Liang Piu Koh, MBBS, MRCP, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Wei Ying Jen, MA, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 5237.
https://doi.org/10.1182/blood-2018-99-120327
Published: 2018
Journal Articles

Epidemiology of Patients with Classical Philadelphia-Chromosome Negative Myeloproliferative Neoplasms at a Single Academic Medical Center in Singapore

Priscella Shirley Chia, BSc, Vanessa CL Chong, Ting Yuan Tay, Eng Soo Yap, MBBS, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Xin Liu, Moon Ley Tung, MBBS, MRCP
Journal: Blood
Blood (2018) 132 (Supplement 1): 5478.
https://doi.org/10.1182/blood-2018-99-116728
Published: 2018
Journal Articles

ASLAN003, a Novel and Potent Dihydroorotate Dehydrogenase (DHODH) Inhibitor, Induces Differentiation of Acute Myeloid Leukemia

Jianbiao Zhou, MD,PhD, Jessie Yiying Quah, B.S., Jing Yuan Chooi, BSc, Sabrina Hui-Min Toh, B.S., Yvonne Ng, B.S., Baohong Lin, B.S., Motomi Osato, MD, PhD, Qihui Seet, B.S., PhD, A.G. Lisa Ooi, B.S., PhD, Bertil Lindmark, MD PhD, Mark McHale, B.S., PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4047.
https://doi.org/10.1182/blood-2018-99-114392
Published: 2018
Journal Articles

Asian Subgroup Analysis - Denosumab Vs Zoledronic Acid in Bone Disease Treatment of Newly Diagnosed Multiple Myeloma: An International, Double-Blind, Double-Dummy, Randomized Controlled Phase 3 Study

Chang-Ki Min, MD PhD, Sung-Soo Yoon, MD PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Shang-Yi Huang, MD, PhD, Cheng-Shyong Chang, MD, Raymond Siu Ming Wong, Kazuyuki Shimizu, MD PhD, Nan Gao, Anthony Glennane, MD, Xuesong Guan
Journal: Blood
Blood (2018) 132 (Supplement 1): 3251.
https://doi.org/10.1182/blood-2018-99-113132
Published: 2018
Journal Articles

Overall Survival (OS) Benefit of Oral Ixazomib in Combination with Lenalidomide and Dexamethasone (IRd) Vs Lenalidomide and Dexamethasone (Rd) in Asian Patients (pts) with Relapsed and/or Refractory Multiple Myeloma (RRMM): Pooled-Analysis from the Tourmaline-MM1 and the China Continuation Studies

Weijun Fu, MD PhD, Jin Lu, Jie Jin, MD PhD, Yan Xu, MD, Depei Wu, Dao-bin Zhou, MD, Xiaoyan Ke, Xin Du, MD PhD, Xiequn Chen, MD PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Kihyun Kim, MD PhD, Junmin Li, MD PhD, Jae Hoon Lee, MD PhD, Jing Liu, PhD, Yeow Tee Goh, MBBS, MD, Kwang-Wei Wu, MD, Hui Wang, MD, Guohui Liu, PhD, Tomas Skacel, MD PhD, Hui Wan, MD PhD, Deborah Berg, RN, MSN
Journal: Blood
Blood (2018) 132 (Supplement 1): 5637.
https://doi.org/10.1182/blood-2018-99-116844
Published: 2018
Journal Articles

Overexpressed Melk Promotes the Stability of EZH2 through Phosphorylation in Natural Killer/T Cell Lymphoma (NKTL)

Boheng Li, PhD, Dennis Kappei, PhD, Junli Yan, PhD, Pieter Eichhorn, PhD, Siok Bian Ng, FRCPA, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 2858.
https://doi.org/10.1182/blood-2018-99-110758
Published: 2018
Journal Articles

Maintenance Therapy with the Oral Proteasome Inhibitor (PI) Ixazomib Significantly Prolongs Progression-Free Survival (PFS) Following Autologous Stem Cell Transplantation (ASCT) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Phase 3 Tourmaline-MM3 Trial

Meletios A Dimopoulos, MD, Francesca Gay, MDPhD, Fredrik H. Schjesvold, MDPhD, Meral Beksac, MD, Roman Hajek, Katja Weisel, MD, Hartmut Goldschmidt, MD, Vladimir Maisnar, MD, Philippe Moreau, Chang-Ki Min, MD PhD, Agnieszka Pluta, MD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS, Martin Kaiser, MD, Sonja Zweegman, MDPhD, Maria-Victoria Mateos, MD PhD, Andrew Spencer, MBBS, FRACP, FRCPA, DM, Shinsuke Iida, MDPhD, Gareth Morgan, MD, Zhaoyang Teng, PhD, Kaveri Suryanarayan, MD, Tomas Skacel, MD PhD, Ajeeta B Dash, PhD, Richard Labotka, MD, S. Vincent Rajkumar, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 301.
https://doi.org/10.1182/blood-2018-99-112079
Published: 2018
Journal Articles

Evaluation of Maintenance Therapy in Myeloma in an Asian Population

Cinnie Yentia Soekojo, MD MRCP, Sanjay De Mel, Melissa Ooi, MB BCh, BAO, MRCP(I), FRCPath, PhD, Wee Joo Chng, MB ChB, PhD FRCP(UK), FRCPath, FAMS
Journal: Blood
Blood (2018) 132 (Supplement 1): 3231.
https://doi.org/10.1182/blood-2018-99-110624
Published: 2018